Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.88 USD | +1.95% | +1.73% | -46.34% |
04-16 | HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating | MT |
03-27 | Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.67M 1.01B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.32% |
1 day | +1.95% | ||
1 week | +1.73% | ||
Current month | -28.46% | ||
1 month | -21.78% | ||
3 months | -30.71% | ||
6 months | -23.48% | ||
Current year | -46.34% |
Managers | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 01/08/88 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 31/12/21 |
Chief Tech/Sci/R&D Officer | - | 11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 27/11/16 |
Director/Board Member | 66 | 11/12/17 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 31/07/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.88 | +1.95% | 31,899 |
25/04/24 | 0.8632 | -3.12% | 74,549 |
24/04/24 | 0.891 | +1.26% | 82,757 |
23/04/24 | 0.8799 | -0.86% | 88,648 |
22/04/24 | 0.8875 | +2.60% | 125,298 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.34% | 12.67M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MBOT Stock